Regeneron Pharmaceuticals (REGN) EBIT (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.93% |
| Dec 31, 2025 | -14.31% |
| Sep 30, 2025 | -4.88% |
| Jun 30, 2025 | 82.44% |
| Mar 31, 2025 | -40.24% |
| Dec 31, 2024 | -16.05% |
| Sep 30, 2024 | 10.27% |
| Jun 30, 2024 | 42.35% |
| Mar 31, 2024 | -22.77% |
| Dec 31, 2023 | -12.43% |
| Sep 30, 2023 | 9.30% |
| Jun 30, 2023 | 7.37% |
| Mar 31, 2023 | -17.45% |
| Dec 31, 2022 | -6.28% |
| Sep 30, 2022 | 10.25% |
| Jun 30, 2022 | -11.81% |
| Mar 31, 2022 | -52.32% |
| Dec 31, 2021 | 42.90% |
| Sep 30, 2021 | -44.81% |
| Jun 30, 2021 | 200.82% |
| Mar 31, 2021 | -4.65% |
| Dec 31, 2020 | 10.82% |
| Sep 30, 2020 | 60.44% |
| Jun 30, 2020 | -6.24% |
| Mar 31, 2020 | 3.61% |
| Dec 31, 2019 | -8.50% |
| Sep 30, 2019 | 134.00% |
| Jun 30, 2019 | -34.25% |
| Mar 31, 2019 | -33.16% |
| Dec 31, 2018 | 14.55% |
| Sep 30, 2018 | 0.76% |
| Jun 30, 2018 | 9.70% |
| Mar 31, 2018 | 5.27% |
| Dec 31, 2017 | -3.77% |
| Sep 30, 2017 | 1.75% |
| Jun 30, 2017 | 27.82% |
| Mar 31, 2017 | 24.09% |
| Dec 31, 2016 | -4.37% |
| Sep 30, 2016 | 24.41% |
| Jun 30, 2016 | -11.44% |
| Mar 31, 2016 | 42.51% |
| Dec 31, 2015 | -41.11% |
| Sep 30, 2015 | 13.79% |
| Jun 30, 2015 | 21.62% |
| Mar 31, 2015 | 14.63% |
| Dec 31, 2014 | 31.25% |
| Sep 30, 2014 | -17.37% |
| Jun 30, 2014 | 19.07% |
| Mar 31, 2014 | -1.81% |
| Dec 31, 2013 | -17.61% |
| Sep 30, 2013 | 49.78% |
| Jun 30, 2013 | 3.30% |
| Mar 31, 2013 | 5.07% |
| Dec 31, 2012 | -28.02% |
| Sep 30, 2012 | 131.33% |
| Jun 30, 2012 | 294.03% |
| Mar 31, 2012 | 148.90% |
| Dec 31, 2011 | 22.33% |
| Sep 30, 2011 | 3.09% |
| Jun 30, 2011 | -47.19% |
| Mar 31, 2011 | -220.74% |
| Dec 31, 2010 | 60.19% |
| Sep 30, 2010 | -35.28% |
| Jun 30, 2010 | 17.84% |
| Mar 31, 2010 | 26.72% |
| Dec 31, 2009 | -2,952.52% |
| Sep 30, 2009 | 92.06% |